
Regulatory tracker: Europe serves up earlier lymphoma nod for Roche's Columvi as final review of Eisai's Leqembi kicks ...
Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Be sure to come back regularly for …